CardioGenics Holdings Inc CGNH:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 02/01/24 EDT
0.00UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/13/23
  • 52 Week Low0.00
  • 52 Week Low Date02/01/24

Key Stats

  • Market Cap96.051
  • Shares Out96.05M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.00
  • 52 Week High0.00
  • 52 Week High Date10/13/23
  • 52 Week Low0.00
  • 52 Week Low Date02/01/24
  • Market Cap96.051
  • Shares Out96.05M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta1.32
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-753,549.993
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-21.19%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On CardioGenics Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CardioGenics Holdings Inc. is focused on technology and products targeting the immunoassay segment of the In-Vitro Diagnostic testing market. The Company has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform...
J. Tabatznik
Director/Acting Chairman
Yahia Gawad M.D.
Director & Chief Executive Officer
James Essex
Chief Financial Officer
Address
6865 SW 18th St Ste B13
Boca Raton, FL
33433-7057
United States